Press Release Source: Upsher-Smith Laboratories, Inc.
Upsher-Smith Launches Clenia(TM) (Sodium Sulfacetamide 10% and Sulfur 5%) Foaming Wash and Emollient Cream to Combat Acne Rosacea, Acne Vulgaris and Seborrheic Dermatitis
Thursday March 6, 3:15 pm ET
Pleasant Scent and Alcohol-Free Formulation Set Clenia(TM) Foaming Wash And Emollient Cream Apart From Other Sodium Sulfacetamide/Sulfur Products
PLYMOUTH, Minn., March 6 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., building on a solid reputation of creating effective dermatological products, is launching Clenia(TM) (sodium sulfacetamide 10% and sulfur 5%) Foaming Wash and Clenia(TM) (sodium sulfacetamide 10% and sulfur 5%) Emollient Cream. The two Clenia(TM) products offer a complete system -- with the foaming wash designed for control and the emollient cream for treating specific lesions. The Clenia(TM) products are indicated for treatment of acne rosacea, acne vulgaris and seborrheic dermatitis.(1) Sodium sulfacetamide 10% and sulfur 5% provide significant results in one to four weeks.(2,3)
Clenia(TM) Emollient Cream, designed to maintain the skin's natural moisture, is the only cream of its kind currently on the market. Upsher-Smith has revolutionized the scent of sodium sulfacetamide/sulfur products, which can be strong and unpleasant. Both Clenia(TM) products are alcohol-free with a uniquely pleasant breezy scent.
"Compliance with a skin-care regimen is easier when the product is effective, even more so when it smells and feels good," says Phillip Dritsas, Vice President of Sales and Marketing for Upsher-Smith Laboratories, Inc.
Clenia(TM) Foaming Wash is sold in six- and 12-ounce bottles with pumps. Clenia(TM) Emollient Cream's patent pending formulation is packaged in one-ounce tubes.
About Upsher-Smith Laboratories. Founded in 1919, Upsher-Smith Laboratories, Inc. is a rapidly growing, fully-integrated pharmaceutical company and a recognized leader in the development of dermatological and cardiovascular products. The company develops, manufactures and markets prescription pharmaceutical products and is actively involved in licensing innovative compounds that are currently in clinical development. For more information about Upsher-Smith Laboratories, call 1.800.654.2299 or visit
www.upsher-smith.com .
